Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-21-052393

SVP & General Counsel sold 1,910 shares at $13.83 ($26,415)

From the SEC's structured data for this filing

Trades in this filing

Wilson Mark Andrew · SVP & General Counsel

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2021-08-16 Sale : show line 1 in the form −1,910 $13.83 $26,415 72,900 D
Open-market sales · 1,910 sh · avg $13.83 · $26,415
Loading xslF345X03/doc4.xml…